Home Cart Sign in  
Chemical Structure| 175026-96-7 Chemical Structure| 175026-96-7

Structure of NQDI-1
CAS No.: 175026-96-7

Chemical Structure| 175026-96-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

NQDI-1 is a selective inhibitor of apoptosis signal-regulating kinase 1 (ASK1) with IC50 of 3 μM and Ki of 500 nM.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of NQDI-1

CAS No. :175026-96-7
Formula : C19H13NO4
M.W : 319.31
SMILES Code : O=C(C1=C2C3=C(NC1=O)C=CC=C3C(C4=C2C=CC=C4)=O)OCC
MDL No. :MFCD03265970
InChI Key :UFJGFNHRMPMALC-UHFFFAOYSA-N
Pubchem ID :5522952

Safety of NQDI-1

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of NQDI-1

MAPK

Isoform Comparison

Biological Activity

Target
  • ASK1

    ASK1, IC50:3 μM

In Vitro:

Cell Line
Concentration Treated Time Description References
BV-2 cells 10 μM 24 h NQDI1 decreased the phosphorylation and expression of ASK1, reduced the phosphorylation of p-38 and JNK, decreased the activity and the expression of MMP-9, and inhibited IBA-1 expression. J Neuroinflammation. 2023 Feb 3;20(1):22.
SKOV3 cells 10 μM 24 h Inhibition of ASK1 expression, reduction of total Noxa protein and mitochondrial localization, and increase in Bcl-2 expression, thereby attenuating low glucose and metformin-induced apoptosis J Exp Clin Cancer Res. 2019 Feb 13;38(1):77.
mouse embryonic fibroblasts (MEFs) 10 μM, 30 μM, 50 μM 24 h To determine the inhibitory effect of NQDI-1 on ASK1 phosphorylation, results showed that 10 μM NQDI-1 reduced ASK1 phosphorylation to 40% of control, 30 μM almost completely inhibited, and 50 μM completely inhibited ASK1, JNK, and p38 phosphorylation. Cell Death Dis. 2014 Nov 13;5(11):e1522.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Postoperative pain model Intrathecal injection 5 μg/10 μl Once daily for 5 days NQDI-1 decreased the phosphorylation of ASK1, p-38, and JNK, reduced the activity and expression of MMP-9, and attenuated postoperative pain. J Neuroinflammation. 2023 Feb 3;20(1):22.
Nude mice Ovarian cancer xenograft model Intraperitoneal injection 1 mg/kg Once daily until tumor volume reached 150-200 mm3 To evaluate the inhibitory effect of NQDI-1 on the anti-tumor activity of metformin, it was found that NQDI-1 weakened the anti-tumor effect of metformin alone J Exp Clin Cancer Res. 2019 Feb 13;38(1):77.
Mice Ectopic ossification model Subcutaneous injection 30 μM Single injection, lasting 2 weeks To evaluate the effect of NQDI-1 on ectopic ossification, results showed that 30 μM NQDI-1 increased bone volume by 64%, comparable to the 82% increase observed in ASK1 KO mice. Cell Death Dis. 2014 Nov 13;5(11):e1522.
Mice Intracerebral hemorrhage model Intracerebroventricular injection 250 nM/mouse Single dose 30 min before ICH induction NQDI-1 alone improved neurological functions and down-regulated ASK1/JNK/p38 MAPK expression after ICH. Br J Pharmacol. 2019 May;176(9):1341-1356
Mice Liver ischemia/reperfusion injury model Intraperitoneal injection 10 mg/kg Single injection, lasting until 6 hours after reperfusion NQDI-1 alleviates liver ischemia/reperfusion injury by inhibiting the ASK1-JNK/P38 signaling pathway Front Pharmacol. 2022 Sep 8;13:951906

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.13mL

0.63mL

0.31mL

15.66mL

3.13mL

1.57mL

31.32mL

6.26mL

3.13mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories